Vidcast:  https://youtu.be/kRgzAcvwbX4

 

A new gene assay called CovGENE predicts whether a CoVid-infected person will develop a severe, life-threatening case more than 90% of the time.   University of Virginia investigators performed genetic analyses on 39 of their own patients and used analyses carried out on 100 patients at 2 other medical centers.

 

CoVid patients with severe respiratory failure showed a characteristic genetic immune cell signature that correlated with worse clinical outcomes.  The CovGENE developer, AMPEL Biosolutions, is now seeking to partner with a diagnostic test company to develop their technology into a simple PCR type test.

 

https://www.frontiersin.org/articles/10.3389/fimmu.2022.989556/full

 

#CoVid #covgene #ahrf